Our US Grantees

aimee edingner

Aimee Edinger, VMD, Ph.D.

University of California, Irvine Role of regulated nutrient transporter expression in suppressing leukemia and lymphoma development...more


Alan B. Cantor, M.D., Ph.D.

Children's Hospital Boston, Dana-Farber Cancer Institute Inhibition of Runx1 Tyrosine Phosphorylation in the Treatment of Human Leukemia...more


Alejandro Gutierrez, M.D.

Boston Children's HospitalTherapeutic Activation of the PP2A Tumor Suppressor in High-Risk T-cell Acute Lymphomblastic Leukemia...more


Alex Kentsis, MD, PhD

Memorial Sloan Kettering Cancer Center Blockade of autocrine signaling for curative therapy of acute myeloid leukemia...more

alex huang

Alex Y. C. Huang, M.D., Ph.D.

Case Western Reserve University Modulation of Immune Cell Homing and Interaction by Mesenchymal Stem Cell within CNS Tumor Microenvironment...more

amanda larson

Amanda Gedman Larson, Ph.D.

St. Jude Children's Research Hospital The Molecular Genetics of Acute Megakaryocytic Leukemia...more

amit verma

Amit Verma, M.D.

Albert Einstein College of Medicine TGF beta receptor inhibition as a therapeutic strategy in Myelodysplastia...more


Andrea Ventura, M.D., Ph.D.

Memorial Sloan-Kettering Cancer CenterInvestigating the roles of microRNAs in lymphomagenesis...more

andreas beutler

Andreas Beutler, M.D.

Mount Sinai School of Medicine An Integrative Approach to the Control of Intractable Pain from Cancer such as Multiple Myeloma...more

andrew lane

Andrew A. Lane, MD, PhD

Dana-Farber Cancer InstituteIdentifying vulnerabilities in hematologic malignancies driven by heterotrimeric G proteins...more

andrew rezvanni

Andrew Rezvani, M.D.

Fred Hutchinson Cancer Research Center The Role of Rituximab in Allogeneic Hematopoietic Cell Transplantation for B-Cell Non-Hodgkin Lymphoma...more

anil prasad

Anil Prasad, Ph.D.

Beth Israel Deaconess Medical Center Characterization of Cannabidiol (CBD) as a Novel Therapy for Mantle Cell Lymphoma...more

anthony brickner

Anthony G. Brickner, Ph.D.

University of Pittsburgh Cancer Institute Identifying stop codon-generated minor histocompatibility antigens capable of eliciting potent GVL or GVHD alloresponses...more

anthony letai

Anthony G. Letai, M.D., Ph.D.

Dana-Farber Cancer Institute, Harvard University Detecting blocks in Apoptosis in Leukemia Stem Cells...more


Arash Ash Alizadeh, M.D., Ph.D.

Stanford University School of MedicineProspective Validation and Genetic Basis of a Novel Molecular Risk Predictor for Diffuse large B-Cell Lymphoma...more

ari melnick

Ari M. Melnick, M.D.

Albert Einstein College of Medicine The Bcl-6 oncoprotein as a target for transcription therapy...more


Arnob Banerjee, M.D., Ph.D.

University of Maryland School of MedicineGenomic and Functional Identification of Critical Targets in Peripheral T Cell Lymphoma...more


Arun P. Wiita, MD, PhD

University of California, San Francisco Blockade of the HSP70-BAG3 chaperone/co-chaperone interaction to overcome proteasome inhibitor-refractory multiple myeloma...more


Aude Chapuis, MD

Fred Hutchinson Cancer Research Center WT1-targeting adoptive T cell therapy for AML patients at high risk for relapse...more

ben croker

Ben A. Croker, PhD

Boston Children's HospitalGene editing in ALL to promote immunomodulatory forms of lytic cell death...more